SpringerLink
Log in

Imatinib/interferon alpha

Enteric toxicity and JAK2 mutated polycythaemia: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Lapietra G, et al. Late appearance of JAK2 mutated polycythaemia vera in a patient with typical chronic myeloid leukaemia on imatinib: Speculations about role of therapeutic pressure and of secondary genetic events. Leukemia Research 126: Mar 2023. Available from: URL: http://doi.org/10.1016/j.leukres.2023.107035

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Imatinib/interferon alpha. Reactions Weekly 1971, 133 (2023). https://doi.org/10.1007/s40278-023-45258-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-45258-y

Search

Navigation